Home Current issue Ahead of print Search About us Editorial board Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 613
  • Home
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2022  |  Volume : 14  |  Issue : 2  |  Page : 161-164

Mucormycosis: An emerging concern of orofacial complication in COVID-19 infection


Department of Pediatric and Preventive Dentistry, ITS Dental College, Hospital and Research Centre, Greater Noida, Uttar Pradesh, India

Correspondence Address:
Anam Mushtaq
Department of Pediatric and Preventive Dentistry, ITS Dental College, Hospital and Research Centre, Greater Noida, Uttar Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jorr.jorr_72_21

Rights and Permissions

Coronavirus disease (COVID-19) infection has been seen to be associated with secondary bacterial and fungal infections. Mucormycosis has been increasingly reported in patients with COVID-19 infection, especially those with underlying medical conditions such as diabetes mellitus and on steroid therapy. It is an acute invasive fungal infection primarily affecting individuals with suppressed immune system. This article presents the characteristics of mucormycosis infection and its etiological association with COVID-19. Its diagnosis and management based on the current guidelines have also been discussed in this literature review.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed112    
    Printed4    
    Emailed0    
    PDF Downloaded19    
    Comments [Add]    

Recommend this journal